POZN - POZEN, Inc.

POZEN Inc. (POZEN)is a pharmaceutical company focused on transforming medicine. The Company has developed Treximet in collaboration with GlaxoSmithKline (GSK). Treximet is the brand name for the product combining sumatriptan 85 milligram, formulated with RT Technology and naproxen sodium 500 milligram in a single tablet designed for the acute treatment of migraine. The Company is also developing product candidates that combine a type of acid inhibitor, a proton pump inhibitor (PPI), with an non-steroidal anti-inflammatory drug (NSAID) (its PN program). These product candidates focuses on providing management of pain and inflammation associated with conditions, such as osteoarthritis, with fewer gastrointestinal complications compared to an NSAID taken alone. Its PA product candidates, containing a combination of a PPI and aspirin, are in formulation and clinical development testing.